Skip to main content
Log in

Stem cells

iPS cells under attack

  • News & Views
  • Published:

From Nature

View current issue Submit your manuscript

Induced pluripotent stem cells offer promise for patient-specific regenerative therapy. But a study now cautions that, even when immunologically matched, these cells can be rejected after transplantation. See Letter p.212

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Immunogenicity of induced pluripotent stem cells.

References

  1. Takahashi, K. & Yamanaka, S. Cell 126, 663–676 (2006).

    Article  CAS  Google Scholar 

  2. Stadtfeld, M. & Hochedlinger, K. Genes Dev. 24, 2239–2263 (2010).

    Article  CAS  Google Scholar 

  3. Wu, S. M. & Hochedlinger, K. Nature Cell Biol. 13, 497–505 (2011).

    Article  CAS  Google Scholar 

  4. Zhao, T., Zhang, Z.-N., Rong, Z. & Xu, Y. Nature 474, 212–215 (2011).

    Article  CAS  Google Scholar 

  5. Kim, K. et al. Nature 467, 285–290 (2010).

    Article  ADS  CAS  Google Scholar 

  6. Polo, J. M. et al. Nature Biotechnol. 28, 848–855 (2010).

    Article  CAS  Google Scholar 

  7. Hanna, J. et al. Science 318, 1920–1923 (2007).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Konrad Hochedlinger.

Ethics declarations

Competing interests

K.H. is an adviser to iPerian, Inc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Apostolou, E., Hochedlinger, K. iPS cells under attack. Nature 474, 165–166 (2011). https://doi.org/10.1038/474165a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/474165a

  • Springer Nature Limited

This article is cited by

Navigation